Weaver Consulting Group’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Sell |
10,157
-210
| -2% | -$5.09K | 0.07% | 207 |
|
|
2025
Q1 | $263K | Sell |
10,367
-308
| -3% | -$7.81K | 0.08% | 190 |
|
|
2024
Q4 | $283K | Sell |
10,675
-2,638
| -20% | -$70K | 0.09% | 167 |
|
|
2024
Q3 | $385K | Buy |
13,313
+65
| +0.5% | +$1.88K | 0.12% | 136 |
|
|
2024
Q2 | $371K | Buy |
13,248
+226
| +2% | +$6.32K | 0.13% | 131 |
|
|
2024
Q1 | $361K | Buy |
13,022
+2,980
| +30% | +$82.7K | 0.13% | 137 |
|
|
2023
Q4 | $289K | Buy |
+10,042
| New | +$289K | 0.12% | 149 |
|
|
2023
Q2 | – | Sell |
-5,179
| Closed | -$211K | – | 189 |
|
|
2023
Q1 | $211K | Sell |
5,179
-397
| -7% | -$16.2K | 0.1% | 168 |
|
|
2022
Q4 | $286K | Buy |
5,576
+18
| +0.3% | +$922 | 0.15% | 134 |
|
|
2022
Q3 | $243K | Sell |
5,558
-80
| -1% | -$3.5K | 0.14% | 137 |
|
|
2022
Q2 | $296K | Sell |
5,638
-115
| -2% | -$6.04K | 0.17% | 124 |
|
|
2022
Q1 | $298K | Sell |
5,753
-396
| -6% | -$20.5K | 0.14% | 132 |
|
|
2021
Q4 | $363K | Sell |
6,149
-50
| -0.8% | -$2.95K | 0.17% | 110 |
|
|
2021
Q3 | $267K | Buy |
6,199
+56
| +0.9% | +$2.41K | 0.15% | 123 |
|
|
2021
Q2 | $241K | Sell |
6,143
-221
| -3% | -$8.67K | 0.14% | 126 |
|
|
2021
Q1 | $231K | Buy |
6,364
+573
| +10% | +$20.8K | 0.14% | 123 |
|
|
2020
Q4 | $213K | Sell |
5,791
-17
| -0.3% | -$625 | 0.13% | 128 |
|
|
2020
Q3 | $202K | Hold |
5,808
| – | – | 0.12% | 120 |
|
|
2020
Q2 | $180K | Buy |
5,808
+318
| +6% | +$9.86K | 0.1% | 137 |
|
|
2020
Q1 | $170K | Sell |
5,490
-1,663
| -23% | -$51.5K | 0.11% | 118 |
|
|
2019
Q4 | $244K | Buy |
7,153
+2,338
| +49% | +$79.8K | 0.13% | 99 |
|
|
2019
Q3 | $177K | Buy |
4,815
+844
| +21% | +$31K | 0.09% | 115 |
|
|
2019
Q2 | $163K | Hold |
3,971
| – | – | 0.09% | 113 |
|
|
2019
Q1 | $162K | Buy |
+3,971
| New | +$162K | 0.05% | 243 |
|